Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SPRO Spero Therapeutics Inc.

盘前交易 03-27 07:03:38 EDT

2.37

-0.04

-1.66%

盘前2.28

-0.09-3.80%

06:42 EDT

最高2.48	最低2.34	成交量48.26万
今开2.39	昨收2.41	日振幅5.81%
总市值1.34亿	流通市值1.09亿	总股本5,634万
成交额116.60万	换手率1.05%	流通股本4,580万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SPRO","market":"US","secType":"STK","nameCN":"Spero Therapeutics Inc.","latestPrice":2.37,"timestamp":1774555200000,"preClose":2.41,"halted":0,"volume":482614,"hourTrading":{"tag":"盘前","latestPrice":2.28,"preClose":2.37,"latestTime":"06:42 EDT","volume":1,"amount":2.28,"timestamp":1774608156628,"change":-0.09,"changeRate":-0.037975,"amplitude":0},"delay":0,"changeRate":-0.016597510373443997,"floatShares":45804555,"shares":56339295,"eps":-0.790454,"marketStatus":"盘前交易","change":-0.04,"latestTime":"03-27 07:03:38 EDT","open":2.39,"high":2.48,"low":2.34,"amount":1165994.5552948,"amplitude":0.058091,"askPrice":2.45,"askSize":100,"bidPrice":2.37,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.790454,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774618200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1509595200000,"exchange":"NASDAQ","adjPreClose":2.37,"preHourTrading":{"tag":"盘前","latestPrice":2.28,"preClose":2.37,"latestTime":"06:42 EDT","volume":1,"amount":2.28,"timestamp":1774608156628,"change":-0.09,"changeRate":-0.037975,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.47,"preClose":2.37,"latestTime":"19:48 EDT","volume":59166,"amount":145689.0571,"timestamp":1774568938500,"change":0.1,"changeRate":0.042194,"amplitude":0.054852},"volumeRatio":2.0136117215912894,"impliedVol":1.1007,"impliedVolPercentile":0.616},"requestUrl":"/m/hq/s/SPRO","defaultTab":"news","newsList":[{"id":"1119642553","title":"Spero Therapeutics将于2026年3月26日公布2025财年第四季度及全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1119642553","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119642553?lang=zh_cn&edition=full","pubTime":"2026-03-19 04:07","pubTimestamp":1773864458,"startTime":"0","endTime":"0","summary":"生物制药公司Spero Therapeutics宣布，将于2026年3月26日公布2025财年第四季度及全年财务业绩，并同步举行电话会议讨论业务进展。此次财报将披露公司在抗菌药物研发管线的关键运营指标、现金流状况及临床项目里程碑。Spero Therapeutics专注于开发应对多重耐药菌感染的创新疗法，核心产品tebipenem HBr作为口服碳青霉烯类抗生素，针对复杂性尿路感染已进入商业化准备阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRO"],"gpt_icon":0},{"id":"1131321261","title":"Spero 宣布 GSK 向 FDA 重新提交 Tebipenem Hbr 的 NDA 用于治疗复杂性尿路感染，包括肾盂肾炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1131321261","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131321261?lang=zh_cn&edition=full","pubTime":"2025-12-19 21:06","pubTimestamp":1766149562,"startTime":"0","endTime":"0","summary":"Spero 宣布 GSK 向 FDA 重新提交 Tebipenem Hbr 的 NDA，用于治疗复杂性尿路感染，包括肾盂肾炎。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SPRO"],"gpt_icon":0},{"id":"1154793410","title":"葛兰素史克：Tebipenem Hbr的安全性概况与Imipenem-Cilastatin及其他碳烯烃类抗生素大致相似","url":"https://stock-news.laohu8.com/highlight/detail?id=1154793410","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154793410?lang=zh_cn&edition=full","pubTime":"2025-10-21 14:01","pubTimestamp":1761026479,"startTime":"0","endTime":"0","summary":"葛兰素史克：Tebipenem Hbr的安全性概况与Imipenem-Cilastatin及其他碳烯烃类抗生素大致相似","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1400636657.SGD","LU1015430645.USD","GSK.UK","LU0971552673.USD","LU1400636574.HKD","LU1202635105.USD","LU0203347892.USD","LU0211331839.USD","BK5011","LU1228905540.USD","LU0321505868.SGD","IE00BWDBJ516.SGD","LU0575583348.USD","LU0058720904.USD","LU1302929846.USD","LU0225284248.USD","LU0161305163.EUR","LU1064927863.SGD","LU1035777561.USD","LU1481600234.SGD","SPRO","LU1309081286.SGD","LU0971552830.HKD","BK4139","LU1098665638.USD","LU1645745479.HKD","LU0306806265.USD","LU1228905037.USD","IE0034235071.USD","LU0225771236.USD","LU0545562505.USD","LU0306807586.USD","LU1670756490.USD","LU0109981661.USD","LU0289739699.SGD","LU1400636491.USD","LU0985481810.HKD","LU1046248800.SGD","LU1487256676.USD","LU0203345920.USD","LU1481599808.USD","LU0321505439.SGD","IE00BQJZX424.USD"],"gpt_icon":0},{"id":"1188960996","title":"葛兰素史克：数据显示Tebipenem Hbr作为首个口服碳青霉烯类抗生素治疗复杂尿路感染的潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1188960996","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188960996?lang=zh_cn&edition=full","pubTime":"2025-10-21 14:01","pubTimestamp":1761026477,"startTime":"0","endTime":"0","summary":"葛兰素史克：数据显示Tebipenem Hbr作为首个口服碳青霉烯类抗生素治疗复杂尿路感染的潜力","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1481600234.SGD","IE0034235071.USD","LU1035777561.USD","IE00BQJZX424.USD","LU0306806265.USD","GSK.UK","BK4139","LU0321505868.SGD","LU0225771236.USD","LU0203347892.USD","LU1400636657.SGD","LU1487256676.USD","LU0225284248.USD","LU1228905540.USD","LU1645745479.HKD","LU1202635105.USD","LU0575583348.USD","SPRO","LU1481599808.USD","LU0985481810.HKD","BK5011","LU0971552673.USD","LU1228905037.USD","LU0058720904.USD","LU1400636491.USD","LU0321505439.SGD","LU0161305163.EUR","LU0971552830.HKD","LU1015430645.USD","LU0545562505.USD","LU0109981661.USD","LU0306807586.USD","LU1046248800.SGD","LU1098665638.USD","LU1302929846.USD","LU1064927863.SGD","LU0203345920.USD","LU0289739699.SGD","LU1400636574.HKD","LU0211331839.USD","LU1670756490.USD","LU1309081286.SGD","IE00BWDBJ516.SGD"],"gpt_icon":0},{"id":"2516323416","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.81%报0.821美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516323416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516323416?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:35","pubTimestamp":1741012558,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时35分，Spero Therapeutics, Inc.股票出现异动，股价大幅拉升5.81%。截至发稿，该股报0.821美元/股，成交量1.3081万股，换手率0.02%，振幅1.93%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Entero Therapeutics Inc.、Alto Neuroscience, Inc.、Geovax Labs, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.17%、32.30%、29.61%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Pliant Therapeutics, Inc.，振幅分别为21.22%、19.25%、16.66%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223558abe634c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223558abe634c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139"],"gpt_icon":0},{"id":"2514775240","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大跌6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775240?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:23","pubTimestamp":1740414181,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时23分，Spero Therapeutics, Inc.股票出现异动，股价大幅下跌6.03%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为244.73%、110.91%、34.18%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Celularity Inc C/Wts 16/07/2026 ，振幅分别为162.04%、55.69%、54.86%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225002301962eb1cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225002301962eb1cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SPRO","BK4139"],"gpt_icon":0},{"id":"2510380652","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大涨5.47%报0.839美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510380652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510380652?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:41","pubTimestamp":1739284897,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时41分，Spero Therapeutics, Inc.股票出现波动，股价快速拉升5.47%。截至发稿，该股报0.839美元/股，成交量3769股，换手率0.01%，振幅1.13%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.30%。其相关个股中，Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2246.85%、594.59%、232.24%，振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.，振幅分别为33.04%、31.80%、29.38%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241389881bf0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241389881bf0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2509974729","title":"Spero Therapeutics, Inc.盘中异动 快速跳水5.02%报0.820美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509974729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509974729?lang=zh_cn&edition=full","pubTime":"2025-02-08 00:55","pubTimestamp":1738947300,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日00时55分，Spero Therapeutics, Inc.股票出现异动，股价急速跳水5.02%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Conduit Pharmaceuticals Inc.、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为5352.11%、168.60%、102.84%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、67.10%、53.38%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208005501987dc70d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208005501987dc70d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2509412496","title":"Spero Therapeutics, Inc.盘中异动 下午盘股价大跌5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509412496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509412496?lang=zh_cn&edition=full","pubTime":"2025-02-05 04:25","pubTimestamp":1738700748,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日04时25分，Spero Therapeutics, Inc.股票出现波动，股价快速下跌5.97%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Mink Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1952.22%、989.90%、587.97%，振幅较大的相关个股有Azitra Inc、Omega Therapeutics, Inc.、Mink Therapeutics, Inc.，振幅分别为123.99%、59.42%、58.27%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042549987a802a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205042549987a802a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2508914184","title":"Spero Therapeutics, Inc.盘中异动 股价大跌5.44%报0.810美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508914184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508914184?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:47","pubTimestamp":1738594055,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时47分，Spero Therapeutics, Inc.股票出现波动，股价大幅跳水5.44%。截至发稿，该股报0.810美元/股，成交量3.0259万股，换手率0.06%，振幅1.82%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为416.32%、352.70%、216.64%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.，振幅分别为82.67%、50.76%、35.62%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224735abc10b4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224735abc10b4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SPRO"],"gpt_icon":0},{"id":"2505527014","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.26%报0.920美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505527014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505527014?lang=zh_cn&edition=full","pubTime":"2025-01-23 22:42","pubTimestamp":1737643377,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日22时42分，Spero Therapeutics, Inc.股票出现波动，股价大幅拉升5.26%。截至发稿，该股报0.920美元/股，成交量2162股，换手率0.00%，振幅0.00%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Hepion Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Quoin Pharmaceuticals Ltd、Vigil Neuroscience, Inc.较为活跃，换手率分别为2213.85%、518.29%、40.11%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nutriband Inc C/Wts 、Exicure, Inc.，振幅分别为54.22%、49.73%、29.32%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123224258abb5fd66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123224258abb5fd66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2504410189","title":"Spero Therapeutics, Inc.盘中异动 下午盘股价大跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504410189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504410189?lang=zh_cn&edition=full","pubTime":"2025-01-17 02:57","pubTimestamp":1737053834,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日02时57分，Spero Therapeutics, Inc.股票出现波动，股价急速跳水5.26%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Aeon Biopharma, Inc.涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Aeon Biopharma, Inc.较为活跃，换手率分别为1919.58%、1179.99%、732.05%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.，振幅分别为152.94%、131.33%、104.84%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117025715abad88ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117025715abad88ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SPRO","LENZ"],"gpt_icon":0},{"id":"2503642773","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503642773?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:32","pubTimestamp":1736951533,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时32分，Spero Therapeutics, Inc.股票出现异动，股价大幅跳水5.56%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。其相关个股中，Monte Rosa Therapeutics, Inc.、Exicure, Inc.、Generation Bio Co.涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Oncolytics Biotech Inc.较为活跃，换手率分别为185.03%、52.76%、35.39%，振幅较大的相关个股有Onconetix, Inc.、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为12.28%、12.00%、10.72%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232139604b411&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232139604b411&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2503558535","title":"Spero Therapeutics, Inc.盘中异动 下午盘快速下挫5.10%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503558535","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503558535?lang=zh_cn&edition=full","pubTime":"2025-01-14 04:14","pubTimestamp":1736799277,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日04时14分，Spero Therapeutics, Inc.股票出现波动，股价大幅跳水5.10%。截至发稿，该股报0.930美元/股，成交量11.9539万股，换手率0.22%，振幅7.14%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为15456.65%、7913.87%、842.39%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、227.48%、201.86%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114041438aba98167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114041438aba98167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0},{"id":"2494380821","title":"Spero Therapeutics, Inc.盘中异动 股价大涨5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494380821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494380821?lang=zh_cn&edition=full","pubTime":"2024-12-28 00:26","pubTimestamp":1735316767,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日00时26分，Spero Therapeutics, Inc.股票出现波动，股价快速拉升5.94%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.29%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Galectin Therapeutics Inc.、Revolution Medicines Inc C/Wts 17/12/2026 涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为109.91%、51.96%、26.55%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Galectin Therapeutics Inc.、Abpro Holdings, Inc，振幅分别为147.50%、65.39%、62.45%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228002607ab9509ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228002607ab9509ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","SPRO"],"gpt_icon":0},{"id":"2486035811","title":"Spero Therapeutics, Inc.盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486035811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486035811?lang=zh_cn&edition=full","pubTime":"2024-11-25 23:08","pubTimestamp":1732547336,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日23时08分，Spero Therapeutics, Inc.股票出现波动，股价大幅下跌5.17%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Alpha Tau Medical Ltd C/Wts 、Ocean Biomedical Inc C/Wts 14/02/2028 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为96.77%、92.96%、55.10%，振幅较大的相关个股有Apollomics Inc C/Wts 01/04/2028 、180 Life Sciences Corp C/Wts 07/11/2025、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为55.45%、48.93%、47.19%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230856971a8660&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125230856971a8660&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SPRO"],"gpt_icon":0},{"id":"2485076298","title":"Spero Therapeutics, Inc.2024财年第三财季实现净利润-17.15百万美元，同比减少434.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485076298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485076298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291408,"startTime":"0","endTime":"0","summary":"11月23日，Spero Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-17.15百万美元，同比减少434.27%；其中营业收入为7.82百万美元，同比减少66.55%，每股基本收益为-0.32美元。机构评级：截至2024年11月23日，当前有2家机构对Spero Therapeutics, Inc.目标价做出预测，其中目标均价为5.00美元，其中最低目标价为5.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b982&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000359abd7b982&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ"],"gpt_icon":0},{"id":"2485912139","title":"Spero Therapeutics, Inc.盘中异动 快速上涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485912139","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485912139?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:05","pubTimestamp":1732129545,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时05分，Spero Therapeutics, Inc.股票出现异动，股价急速拉升5.12%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1845.78%、1318.25%、952.81%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121030545a2493852&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121030545a2493852&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","BK4139","LENZ"],"gpt_icon":0},{"id":"2484041976","title":"Spero Therapeutics, Inc.盘中异动 下午盘急速下跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484041976","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484041976?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:19","pubTimestamp":1731953962,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时19分，Spero Therapeutics, Inc.股票出现波动，股价快速跳水5.08%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。该公司的候选产品tebipenem pivoxil hydrobromide或tebipenem HBr，是一种口服碳青霉烯类抗生素，用于成人治疗MDR革兰氏阴性菌感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021922abcd0dd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119021922abcd0dd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","SPRO"],"gpt_icon":0},{"id":"2483738405","title":"Spero Therapeutics, Inc.盘中异动 急速跳水6.11%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483738405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483738405?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:13","pubTimestamp":1731604382,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时13分，Spero Therapeutics, Inc.股票出现异动，股价大幅跳水6.11%。Spero Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Molecular Templates, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、奥麦罗制药涨幅较大，Molecular Templates, Inc.、Elevai Labs, Inc.、Pulmatrix, Inc.较为活跃，换手率分别为3406.72%、3163.20%、360.18%，振幅较大的相关个股有Molecular Templates, Inc.、Pulmatrix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为249.67%、112.92%、86.36%。Spero Therapeutics, Inc.公司简介：Spero Therapeutics Inc是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501130298e42b4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111501130298e42b4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRO","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sperotherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0405},{"period":"1month","weight":0.0628},{"period":"3month","weight":0.0216},{"period":"6month","weight":0.254},{"period":"1year","weight":1.6629},{"period":"ytd","weight":0.0172}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0615},{"period":"3month","weight":-0.0655},{"period":"6month","weight":-0.0253},{"period":"1year","weight":0.1345},{"period":"ytd","weight":-0.054}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Spero Therapeutics, Inc.,前称为Spero Therapeutics，LLC，于2013年12月根据特拉华州的法律成立。该公司是一个多资产，临床阶段的生物制药公司，专注于识别、开发和营销治疗MDR细菌感染的新疗法。该公司还拥有一项名为“潜力平台”的平台技术，该公司相信这将开发出能够扩大现有抗生素的范围和效力的药物，包括以前不活跃的抗生素，对抗革兰氏阴性细菌。该公司相信，如果成功地开发和批准该新产品，将会对社区和医院环境中治疗MDR感染的患者产生有意义的影响和重要的商业应用。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.027619},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.041579},{"month":3,"riseRate":0.444444,"avgChangeRate":0.004272},{"month":4,"riseRate":0.25,"avgChangeRate":-0.035686},{"month":5,"riseRate":0.375,"avgChangeRate":0.239464},{"month":6,"riseRate":0.5,"avgChangeRate":0.005648},{"month":7,"riseRate":0.25,"avgChangeRate":-0.061853},{"month":8,"riseRate":0.25,"avgChangeRate":0.025791},{"month":9,"riseRate":0.375,"avgChangeRate":0.142637},{"month":10,"riseRate":0.375,"avgChangeRate":0.001197},{"month":11,"riseRate":0.5,"avgChangeRate":0.018182},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.012412}],"exchange":"NASDAQ","name":"Spero Therapeutics Inc.","nameEN":"Spero Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Spero Therapeutics Inc.,SPRO,Spero Therapeutics Inc.股票,Spero Therapeutics Inc.股票老虎,Spero Therapeutics Inc.股票老虎国际,Spero Therapeutics Inc.行情,Spero Therapeutics Inc.股票行情,Spero Therapeutics Inc.股价,Spero Therapeutics Inc.股市,Spero Therapeutics Inc.股票价格,Spero Therapeutics Inc.股票交易,Spero Therapeutics Inc.股票购买,Spero Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Spero Therapeutics Inc.(SPRO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Spero Therapeutics Inc.(SPRO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}